Trustcore Financial Services, LLC Biocryst Pharmaceuticals Inc Transaction History

Trustcore Financial Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$7.37 - $13.61 $6,633 - $12,249	-900 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$3.37 - $8.61 $3,033 - $7,748	900 New	900 $7,000
Q2 2019 Jul 25, 2019	SELL	$2.91 - $9.15 $69,086 - $217,230	-23,741 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$5.52 - $7.99 $11,040 - $15,980	-2,000 Reduced 7.77%	23,741 $181,000
Q4 2017 Feb 09, 2018	BUY	$4.16 - $5.33 $107,082 - $137,199	25,741	25,741 $126,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Trustcore Financial Services, LLC with notifications on news.